APA (7th ed.) Citation

Prathipati, P., Pathania, A. S., Chaturvedi, N. K., Gupta, S. C., Byrareddy, S. N., Coulter, D. W., & Challagundla, K. B. (2024). SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma. Molecular Therapy: Nucleic Acids, 35(2), . https://doi.org/10.1016/j.omtn.2022.03.014

Chicago Style (17th ed.) Citation

Prathipati, Philip, Anup S. Pathania, Nagendra K. Chaturvedi, Subash C. Gupta, Siddappa N. Byrareddy, Don W. Coulter, and Kishore B. Challagundla. "SAP30, an Oncogenic Driver of Progression, Poor Survival, and Drug Resistance in Neuroblastoma." Molecular Therapy: Nucleic Acids 35, no. 2 (2024). https://doi.org/10.1016/j.omtn.2022.03.014.

MLA (9th ed.) Citation

Prathipati, Philip, et al. "SAP30, an Oncogenic Driver of Progression, Poor Survival, and Drug Resistance in Neuroblastoma." Molecular Therapy: Nucleic Acids, vol. 35, no. 2, 2024, https://doi.org/10.1016/j.omtn.2022.03.014.